Divergent effects of weight reduction and oral anticonception treatment on adrenergic lipolysis regulation in obese women with the polycystic ovary syndrome

Journal of Clinical Endocrinology and Metabolism

Volumn 84, Issue 6, 1999, Pages 2182-2187

  Wahrenberg, Hans ^a   Ek, Ingvar ^a   Reynisdottir, Signy ^a   Carlström, Kjell ^a   Bergqvist, Agneta ^a   Arner, Peter ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

ARTICLE; CLINICAL ARTICLE; CONTRACEPTION; FEMALE; HUMAN; HYPERANDROGENISM; LIPOLYSIS; OBESITY; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; WEIGHT REDUCTION;

FALLOPIA;

EID: 0033305412     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.84.6.2182     Document Type: Article

References (32)

1. Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease
2. Insulin resistance in non-obese patients with polycystic ovarian disease
3. Polycystic ovary syndrome and risk for myocardial infarction
4. The independent effects of polycystic ovary syndrome and obesity on serum concentrations of gonadotrophins and sex steroids in premenopausal women
5. On the paradox of insulin-induced hyperandrogenism in insulin-resistant states
6. Regulation of lipolysis in fat cells
7. A pathogenic role of visceral fat β3-adrenoceptors in obesity
8. Catecholamine resistance in fat cells of women with upper-body obesity due to decreased expression of β2-adrenoceptors
9. Impaired adipocyte lipolysis in non obese women with polycystic ovary syndrome: A possible link to insulin resistance
10. Effects of weight reduction on the regulation of lipolysis in adipocytes of women with upper-body obesity
11. Calculation of free and bound fractions of testosterone and estradiol-17β to plasma proteins at body temperature
12. Free testosterone and testosterone/SHBG index in hirsute women: A comparison of diagnostic accuracy
13. The effect of local anaesthetic agents on lipolysis by human adipose tissue
14. Metabolism of isolated fat cells. I. Effects of hormones on glucose metabolism and lipolysis
15. A simple method to determine fat cell size and number in four mammalian species
16. Methods for determination of adipose cell size and number im man and animals
17. Mechanisms underlying regional differences in lipolysis in human adipose tissue
18. LIGAND: A versatile computerized approach for characterization of ligand binding systems
19. Multiple lipolysis defects in the insulin resistance (metabolic) syndrome
20. 24-hour energy expenditure and sympathetic activity in post-obese women consuming a high-carbohydrate diet
21. Restored insulin sensitivity but persistently increased early insulin secretion after weight loss in obese women with polycystic ovary syndrome
22. Insulin resistance: A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease
23. Activation of ovarian sympathetic nerves in polycystic ovary syndrome
24. Ovarian steroidal response to gonadotropins and beta-adrenergic stimulation is enhanced in polycystic ovary syndrome: Role of sympathetic innervation
25. 5
26. Evidence that lipolytic defect induced by estradiol-treatment in hamster adipocytes is related to an estrogen receptor mediated defect in adenylate cyclase catalytic subunit but not in Ns
27. Steroid hormone receptors in human adipose tissues
28. Identification of oestrogen receptors and oestrogen receptor mRNA in human adipose tissue
29. Effects of estrogen on free fatty acid metabolism in humans
30. Visceral fat accumulation in relation to sex hormones in obese men and women undergoing weight loss therapy
31. Adipose tissue as a source of hormones
32. Catecholamine-induced lipolysis in adipose tissue of the elderly